Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway
ConclusionOur findings repurpose ketotifen for antitumor applications and endorse its clinical development for NEPC therapy, offering a novel and promising therapeutic strategy for this formidable cancer subtype.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Biochemistry | Biology | Brain | Cancer | Cancer & Oncology | Cytology | Databases & Libraries | Hormonal Therapy | Hormones | Neurology | Prostate Cancer